A Public Drug Registry Would Bring Honesty to Pharmaceutical Analysis.

Without a doubt, the pharmaceutical industry depends on the fact they can bury bad results and make sure they are disappear. If those outcomes were to suddenly be made public, and if stringent rules were set up which required all such research to be made public in the future, you can wager the pharmaceutical market would encounter a meltdown caused by the widespread realization that pharmaceuticals really aren’t best for people after all..The new 38 megabase kit design adds content recently determined to be in the expressed genome. This article also is within Agilent’s second item targeting the individual exome, the SureSelect Human All Exon 50 Mb kit, developed in partnership with the Wellcome Trust Sanger Institute and Gencode. ‘We are happy with the most recent end result of our long-standing collaboration with Agilent,’ stated Stacey Gabriel, Ph.D., co-director of the Genome Sequencing Middle at the Broad Institute.